A New Microtechnique for the Analysis of the Human Hepatic Microsomal Glucose-6-phosphatase System

Overview

Journal Clin Chim Acta

Specialty Biochemistry

Date 1988 Apr 15

PMID 2837351

Citations 39

Authors

A Burchell

R HUME

B Burchell

Affiliations

Soon will be listed here.

Abstract

A microtechnique has been developed which enables a complete kinetic analysis of the human hepatic microsomal glucose-6-phosphatase system to be carried out in microsomes isolated from very small liver samples. Complete or partial deficiencies of any of the proteins of the glucose-6-phosphatase system resulting in Type 1a, 1b, 1c or 1d glycogen storage disease can be therefore be diagnosed using hepatic needle biopsy samples, whereas previous methods of diagnosis needed large wedge biopsy samples requiring laparotomy.

Citing Articles

Base-editing corrects metabolic abnormalities in a humanized mouse model for glycogen storage disease type-Ia.

Arnaoutova I, Aratyn-Schaus Y, Zhang L, Packer M, Chen H, Lee C Nat Commun. 2024; 15(1):9729.

PMID: 39523369 PMC: 11551175. DOI: 10.1038/s41467-024-54108-1.

Grape seed extract prevents chlorpyrifos-induced toxicity in rat liver through the modulation of phase I detoxification pathway.

Ghrir S, Ben Abbes W, Chourabi A, Abid G, Jallouli S, Elkahoui S Environ Sci Pollut Res Int. 2024; 31(12):18566-18578.

PMID: 38349500 DOI: 10.1007/s11356-024-32201-8.

Shrimp Glucose-6-phosphatase 2 (G6Pase 2): a second isoform of G6Pase in the Pacific white shrimp and regulation of G6Pase 1 and 2 isoforms via HIF-1 during hypoxia and reoxygenation in juveniles.

Hernandez-Aguirre L, Peregrino-Uriarte A, Duarte-Gutierrez J, Leyva-Carrillo L, Ezquerra-Brauer J, Valenzuela-Soto E J Bioenerg Biomembr. 2023; 55(2):137-150.

PMID: 36853470 DOI: 10.1007/s10863-023-09960-z.

Disruptions in hepatic glucose metabolism are involved in the diminished efficacy after chronic treatment with glucokinase activator.

Tsumura Y, Tsushima Y, Tamura A, Kato H, Kobayashi T PLoS One. 2022; 17(3):e0265761.

PMID: 35312718 PMC: 8936481. DOI: 10.1371/journal.pone.0265761.

Parameterization of Microsomal and Cytosolic Scaling Factors: Methodological and Biological Considerations for Scalar Derivation and Validation.

Doerksen M, Jones R, Coughtrie M, Collier A Eur J Drug Metab Pharmacokinet. 2020; 46(2):173-183.

PMID: 33340340 DOI: 10.1007/s13318-020-00666-w.